Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN

McCourt Marion sold 566 Regeneron Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, McCourt Marion (EVP Commercial) sold 566 Regeneron Pharmaceuticals, Inc. shares at an average US$960.25 for US$544K under a trading plan, leaving 10,305 shares. Filed Nov 18, 2026 (Form 4).

Sold
566 shares
Price
US$960.25 average (US$952.79 to US$971.93)
Value
US$544K
Holding after
10,305 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Commercial

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockSale44US$952.7910,827Direct
Nov 16, 2026Common StockSale59US$954.4610,768Direct
Nov 16, 2026Common StockSale30US$955.5110,738Direct
Nov 16, 2026Common StockSale22US$956.0110,716Direct
Nov 16, 2026Common StockSale44US$958.4710,672Direct
Nov 16, 2026Common StockSale66US$959.4610,606Direct
Nov 16, 2026Common StockSale49US$960.3110,557Direct
Nov 16, 2026Common StockSale59US$961.3610,498Direct
Nov 16, 2026Common StockSale41US$962.4410,457Direct
Nov 16, 2026Common StockSale42US$963.7010,415Direct
Nov 16, 2026Common StockSale21US$964.6910,394Direct
Nov 16, 2026Common StockSale63US$965.6210,331Direct
Nov 16, 2026Common StockSale26US$971.9310,305Direct

Source

Download original · View original at SEC

Related